ELDRED KARY bought GALT
December 23, 2025 · Form 4 insider transaction
ELDRED KARY bought 700 shares of Galectin Therapeutics Inc. at $3.73 per share, a transaction worth $2.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
700
Price
$3.73
Total value
$2.6K
InsiderELDRED KARY
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 23, 2025
Filing dateDecember 23, 2025
Shares owned after65,382
OwnershipDirect
10b5-1 planNo
AmendedNo